Community Programs for Youth and Young Adults at Clinical High Risk for Psychosis
Description
The purpose of this program is to identify youth and young adults, not more than 25 years old, at clinical high risk for psychosis and provide evidence-based interventions to prevent the onset of psychosis or lessen the severity of psychotic disorder.
Award Ceiling
$650K
Total Funding
$8.0M
CFDA Number
93.104
Funding Instrument
Grant
Funding Level
Federal
Jurisdiction
US
Cost Sharing
Yes (0%)
Open Date
May 15, 2026
Close Date
June 15, 2026
Posted Date
May 15, 2026
Eligible Applicant Types
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Tags
HHS-SAMHS-SAMHSACFDA:93.104Cost Sharing RequiredGrantHealth
Related Health & Human Services Grants
NIH Brain Development Cohorts (NBDC) Biospecimen Access (X01 Clinical Trial Not Allowed)
National Institutes of Health
0d left
Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)
National Institutes of Health
0d left
HIV Prevention and Alcohol (R01 Clinical Trials Optional)
National Institutes of Health
0d left
Limited Competition: Small Grant Program for ORIP Special Emphasis Research Career Award (SERCA) K01 Recipients (R03 Clinical Trial Not Allowed)
National Institutes of Health
0d left